PAQ Therapeutics Raises $30M in Series A Funding

20 Jul, 2021

PAQ Therapeutics Raises $30M in Series A Funding
Photo by Sebastian Holgado on Unsplash

– PAQ Therapeutics is a biotechnology company advancing a new approach to restoring health and curing disease through autophagy.
– The company announced the closing of a $30m Series A round.
Sherpa Healthcare Partners led the round with participation from Huagai Capital, MSA Capital, and MRL Ventures Fund as well as seed investors Nest.Bio Ventures and Matrix Partners China.
– The funding will be used to advance the company’s ATTEC platform and progress its pipeline programs.

Biotechnology Health Care North America Therapeutics
Crunchbase icon

Content report

The following text will be sent to our editors: